Right ventricular function in patient with heart failure with reduced ejection fraction and sacubitril/valsartan treatment

被引：0
|
作者：
Mazzeo, Pietro [1 ]
Fortunato, Martino [1 ]
Croella, Francesca [1 ]
Alfieri, Simona [1 ]
Fanizzi, Angela Ilaria [1 ]
Furore, Andrea [1 ]
Ferrara, Salvatore [1 ]
Tricarico, Lucia [1 ]
Correale, Michele [1 ]
Iacoviello, Massimo [1 ]
Di Biase, Matteo [1 ]
Brunetti, Natale D. [1 ]
机构：
[1] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2021年 / 23卷 / SUPPL G期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
61
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Right ventricular function in patient with heart failure with reduced ejection fraction and sacubitril/valsartan treatment
    Mazzeo, Pietro
    Fortunato, Martino
    Croella, Francesca
    Alfieri, Simona
    Fanizzi, Angela Ilaria
    Furore, Andrea
    Ferrara, Salvatore
    Tricarico, Lucia
    Correale, Michele
    Iacoviello, Massimo
    Di Biase, Matteo
    Brunetti, Natale D.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [2] Effects of sacubitril/valsartan on right ventricular function in patients with heart failure and reduced ejection fraction
    Polito, Maria Vincenza
    D'Auria, Federica
    Cogliani, Francesco Maria
    Loria, Francesco
    Vitulano, Gennaro
    De Angelis, Elena
    Rispoli, Antonella
    Silverio, Angelo
    Citro, Rodolfo
    Vecchione, Carmine
    Galasso, Gennaro
    Ciccarelli, Michele
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J125 - J125
  • [3] Effects of Sacubitril/Valsartan on the Right Ventricular Arterial Coupling in Patients with Heart Failure with Reduced Ejection Fraction
    Masarone, Daniele
    Errigo, Vittoria
    Melillo, Enrico
    Valente, Fabio
    Gravino, Rita
    Verrengia, Marina
    Ammendola, Ernesto
    Vastarella, Rossella
    Pacileo, Giuseppe
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10) : 1 - 10
  • [4] Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction
    Khan, Muhammad Nauman
    Soomro, Najia Aslam
    Naseeb, Khalid
    Bhatti, Usman Hanif
    Rauf, Rubina
    Balouch, Iram Jehan
    Moazzam, Ali
    Bashir, Sonia
    Ashraf, Tariq
    Karim, Musa
    [J]. BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [5] Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction
    Muhammad Nauman Khan
    Najia Aslam Soomro
    Khalid Naseeb
    Usman Hanif Bhatti
    Rubina Rauf
    Iram Jehan Balouch
    Ali Moazzam
    Sonia Bashir
    Tariq Ashraf
    Musa Karim
    [J]. BMC Cardiovascular Disorders, 23
  • [6] Impact of Sacubitril–Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Pere Pericas
    Caterina Mas-Lladó
    Maria Francisca Ramis-Barceló
    Isabel Valadrón
    Marta Noris Mora
    Lucía Pasamar Márquez
    Rosa González Colino
    José Francisco Forteza Albertí
    Vicente Peral Disdier
    Xavier Rossello
    [J]. High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 167 - 175
  • [7] Use of Sacubitril/Valsartan in heart failure with reduced ejection fraction
    吴利强
    冯慧婷
    冯慧娟
    [J]. South China Journal of Cardiology, 2019, 20 (04) : 252 - 257
  • [8] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Rex C. Liu
    [J]. American Journal of Cardiovascular Drugs, 2018, 18 : 473 - 482
  • [9] Economic evaluation of sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction
    Stafylas, P.
    Farmakis, D.
    Giamouzis, G.
    Hatzikou, M.
    Kourlaba, G.
    Papatsouma, I.
    Maniadakis, N.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 730 - 731
  • [10] Sacubitril/Valsartan in the primary treatment of heart failure with reduced ejection fraction (HFrEF)
    Nowak, Bernd
    Geiss, Ernst
    Boehm, Michael
    Weil, Joachim
    Boer, Jana
    [J]. KARDIOLOGIE, 2023, : 44 - 48
12345